Healthcare ❯ Medicine

Drug Development

Biotech Startups Antiviral Drugs Alzheimer's Disease Clinical Trials Pharmaceutical Patents

Merck to Acquire EyeBio for Up to $3 Billion

The acquisition aims to bolster Merck's pipeline as it prepares for the loss of Keytruda's patent exclusivity.

FTC Targets 'Junk' Patents to Reduce Drug Prices, Enhances Competition